Suppr超能文献

相似文献

1
Genetics of gigantism and acromegaly.
Growth Horm IGF Res. 2016 Oct-Dec;30-31:37-41. doi: 10.1016/j.ghir.2016.08.002. Epub 2016 Aug 10.
2
Screening for genetic causes of growth hormone hypersecretion.
Growth Horm IGF Res. 2016 Oct-Dec;30-31:52-57. doi: 10.1016/j.ghir.2016.10.004. Epub 2016 Oct 12.
3
[Old phenotype and new genotypes. Pituitary adenomas].
Rev Med Liege. 2015 Nov;70(11):569-74.
4
Familial gigantism.
Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):29-32. doi: 10.6061/clinics/2012(sup01)06.
6
Gigantism: X-linked acrogigantism and GPR101 mutations.
Growth Horm IGF Res. 2016 Oct-Dec;30-31:64-69. doi: 10.1016/j.ghir.2016.09.007. Epub 2016 Sep 29.
7
Pituitary gigantism: Causes and clinical characteristics.
Ann Endocrinol (Paris). 2015 Dec;76(6):643-9. doi: 10.1016/j.ando.2015.10.002. Epub 2015 Nov 14.
8
Pituitary Acrogigantism: From the Past to the Future.
Front Horm Res. 2024;55:82-97. doi: 10.1159/000539941.
10
Genetics of Acromegaly and Gigantism.
J Clin Med. 2021 Mar 29;10(7):1377. doi: 10.3390/jcm10071377.

引用本文的文献

1
Oral Health and Quality of Life in Acromegaly: A Questionnaire-Based Study.
Dent J (Basel). 2025 May 22;13(6):226. doi: 10.3390/dj13060226.
2
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.
Front Endocrinol (Lausanne). 2024 Feb 28;15:1345363. doi: 10.3389/fendo.2024.1345363. eCollection 2024.
3
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.
Nat Rev Endocrinol. 2024 May;20(5):278-289. doi: 10.1038/s41574-023-00948-8. Epub 2024 Feb 9.
4
A worldwide bibliometric analysis of acromegaly in the past two decades: 1999-2022.
Front Neurosci. 2023 Jul 5;17:1187820. doi: 10.3389/fnins.2023.1187820. eCollection 2023.
6
Delving into Acromegaly.
J Clin Med. 2023 Feb 19;12(4):1654. doi: 10.3390/jcm12041654.
7
Development and evaluation of the Acromegaly Symptom Diary.
J Patient Rep Outcomes. 2023 Feb 15;7(1):15. doi: 10.1186/s41687-023-00541-7.
8
The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway.
Front Endocrinol (Lausanne). 2022 Oct 13;13:1024423. doi: 10.3389/fendo.2022.1024423. eCollection 2022.
9
Genetic and Epigenetic Pathogenesis of Acromegaly.
Cancers (Basel). 2022 Aug 10;14(16):3861. doi: 10.3390/cancers14163861.

本文引用的文献

1
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
Acta Neuropathol Commun. 2016 Jun 1;4(1):56. doi: 10.1186/s40478-016-0328-1.
2
Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.
J Clin Endocrinol Metab. 2016 May;101(5):1927-30. doi: 10.1210/jc.2015-4366. Epub 2016 Mar 16.
3
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
Endocrine. 2016 Dec;54(3):762-767. doi: 10.1007/s12020-016-0862-4. Epub 2016 Jan 27.
5
Incidence and prevalence of acromegaly in a large US health plan database.
Pituitary. 2016 Jun;19(3):262-7. doi: 10.1007/s11102-015-0701-2.
6
GHRH excess and blockade in X-LAG syndrome.
Endocr Relat Cancer. 2016 Mar;23(3):161-70. doi: 10.1530/ERC-15-0478. Epub 2015 Dec 15.
7
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
Endocr Relat Cancer. 2015 Oct;22(5):745-57. doi: 10.1530/ERC-15-0320. Epub 2015 Jul 17.
8
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
J Clin Endocrinol Metab. 2015 Sep;100(9):E1242-54. doi: 10.1210/jc.2015-1869.
9
Carney complex: an update.
Eur J Endocrinol. 2015 Oct;173(4):M85-97. doi: 10.1530/EJE-15-0209. Epub 2015 Jun 30.
10
X-linked acrogigantism syndrome: clinical profile and therapeutic responses.
Endocr Relat Cancer. 2015 Jun;22(3):353-67. doi: 10.1530/ERC-15-0038. Epub 2015 Feb 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验